Altium Capital Management LLC 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:35 pm Sale |
2022-12-31 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO |
Altium Capital Management LLC | 0 0.000% |
-41,667 (Position Closed) |
Filing |
| 2022-11-17 5:08 pm Purchase |
2022-11-04 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO |
Altium Capital Management LLC | 41,667 7.700% |
41,667 (New Position) |
Filing |